BioSyent Inc. (OTCMKTS:BIOYF) Sees Significant Decline in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a large decrease in short interest in the month of September. As of September 15th, there was short interest totaling 200 shares, a decrease of 33.3% from the August 31st total of 300 shares. Based on an average daily volume of 1,700 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 1,700 shares, the days-to-cover ratio is presently 0.1 days.

BioSyent Stock Performance

BIOYF stock opened at $8.45 on Wednesday. BioSyent has a 1-year low of $6.49 and a 1-year high of $8.85. The business has a 50 day simple moving average of $8.48 and a two-hundred day simple moving average of $8.27.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.